Ruihao Liang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Locally Advanced

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Lei, Ruihao Liang, Binghua Tan, Lin Li, Yingcheng Lyu, Kexi Wang, Wenjian Wang, Kefeng Wang, Xueting Hu, Duoguang Wu, Huayue Lin, Minghui Wang
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Kai Lei, Ruihao Liang, Binghua Tan, Lin Li, Yingcheng Lyu, Kexi Wang, Wenjian Wang, Kefeng Wang, Xueting Hu, Duoguang Wu, Huayue Lin, Minghui Wang
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Kai Lei, Ruihao Liang, Binghua Tan, Lin Li, Yingcheng Lyu, Kexi Wang, Wenjian Wang, Kefeng Wang, Xueting Hu, Duoguang Wu, Huayue Lin, Minghui Wang
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Kai Lei, Ruihao Liang, Binghua Tan, Lin Li, Yingcheng Lyu, Kexi Wang, Wenjian Wang, Kefeng Wang, Xueting Hu, Duoguang Wu, Huayue Lin, Minghui Wang
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)